XML 87 R3.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Profit or loss [abstract]    
Revenue (Note 16) $ 62,917 $ 41,443
Cost of revenue (Note 17) 11,539 8,365
Gross profit 51,378 33,078
Operating expenses    
General and administrative (Note 18) 16,998 13,140
Sales and marketing (Note 18) 24,020 18,037
Research and development (Note 18) 13,000 9,436
Share-based compensation (Note 14) 1,619 659
Foreign exchange loss 1,775 922
Depreciation and amortization (Note 7, 8 and 9) 1,231 693
Operating expenses 58,643 42,887
Operating loss (7,265) (9,809)
Finance expense, net (Note 11) 130 796
Loss on change in fair value of convertible promissory notes (Note 11) 0 776
Other income (77) (76)
Loss before income taxes 7,318 11,305
Income tax expense (Note 19) 336 609
Net loss for the year (7,654) (11,914)
Item that may be reclassified subsequently to income:    
Exchange (gain) loss on translation of foreign operations (1,002) (652)
Item not subsequently reclassified to income:    
Actuarial loss 108 110
Other comprehensive income (894) (542)
Comprehensive loss $ (6,760) $ (11,372)
Loss per share - basic (in USD per share) $ (0.26) $ (0.49)
Loss per share - diluted (in USD per share) $ (0.26) $ (0.49)
Weighted average number of common shares outstanding - basic (in shares) 28,934,726 24,363,789
Weighted average number of common shares outstanding - diluted (in shares) 28,934,726 24,363,789